Esophagectomy for end-stage achalasia

Area of Science:

• Gastroenterology
• Surgical Oncology

Background:

• End-stage achalasia presents significant challenges due to the esophagus's tortuous path.
• Conservative treatments like Botox, pneumatic dilation, and laparoscopic myotomy often yield suboptimal results in advanced cases.

Purpose of the Study:

• To evaluate the efficacy and outcomes of subtotal esophagectomy for end-stage achalasia.
• To determine if subtotal esophagectomy can restore a viable alimentary condition and improve quality of life.

Main Methods:

• Review of surgical procedures for end-stage achalasia.
• Analysis of outcomes, including morbidity, mortality, and symptom improvement, following subtotal esophagectomy.

Main Results:

• Subtotal esophagectomy is indicated for end-stage achalasia with persistent dysphagia after failed interventions.
• The procedure, when performed by experienced surgeons, demonstrates acceptable postoperative outcomes.
• Patients experience significant symptom improvement and good long-term quality of life.

Conclusions:

• Subtotal esophagectomy is a successful and recommended treatment for end-stage achalasia.
• This surgical approach offers a viable solution for patients with severe, refractory achalasia.